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Recently, loss of endogenous glutathione during N-methyl-D-aspartate (NMDA) receptor-mediated
excitotoxic injury, and the resultant overproduction of reactive oxygen species (ROS) through an
arachidonic acid cascade process in brain, have been implicated in neuronal damage in various
neurodegenerative diseases. Glutathione depletion induced by L-buthionine-(S,R)-sulfoximine (BSO), an
inhibitor of glutathione synthesis, is known to cause arachidonic acid-mediated excitotoxicity in primary
mixed cortical cultures. The aim of this study was to investigate whether esculetin (6,7-dihydroxy-
coumarin), an inhibitor of lipoxygenase, protects against neurotoxicity induced by NMDA or BSO. We
observed that neurotoxicity induced by NMDA but not kainic acid was attenuated by esculetin. At the
same concentration (100 µM), esculetin attenuated the 
45Ca
2+ uptake elevation induced by NMDA. Free
radical-mediated neuronal injury induced by H2O2  and xanthine/xanthine oxidase was concentration-
dependently blocked by esculetin. Esculetin (1-30 µM) dose-dependently inhibited BSO-induced neuronal
injury. In addition, arachidonate-induced neurotoxicity was completely blocked by esculetin. BSO also
reduced glutathione peroxidase (GPx) activity, but did not change glutathione reductase (GR) activity 24 h
after treatment. Esculetin dose-dependently increased GR activity, but did not alter GPx activity. These
findings suggest that esculetin can contribute to the rescue of neuronal cells from NMDA neurotoxicity
and that this protective effect occurs partly through NMDA receptor modulation and the sparing of
glutathione depletion.
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Reactive oxygen species (ROS) produced by excitotoxic
injury during cerebral ischemia contribute to neuronal cell
injury. Glutamate, an important excitatory neurotransmitter
in the central nervous system, stimulates a Ca
2+-dependent
release of arachidonic acid from neuronal cells through the
activation of N-methyl-D-aspartate (NMDA) receptors [1].
Almeida  et al. [2] reported that glutamate neurotoxicity is
a correlate of glutathione depletion. High potassium-induced
glutamate release stimulates the production of arachidonic
acid in cortical neurons [3]. Glutamate is also implicated in
cognitive function, such as learning and memory and in
neurotoxic insult [4]. The activation of NMDA receptors
increases arachidonic acid release in cultured brain cells [5].
The activation of 5-lipoxygenase in arachidonic acid
metabolism appears to correlate with neuronal death caused
by deprivation of endogenous glutathione (GSH) [6]. Although
many modulators or blockers that act on NMDA receptors
have been developed, almost all clinical trials have failed.
Thus, it is urgent to develop a suitable neuroprotective
compound for the rescue of neuronal cells during ischemic
insults in brain. Esculetin is a coumarin derivative that exhibits
various pharmacological actions: it has antioxidant, anti-
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inflammatory, and anti-edematous effects [7]. L-Buthionine-
(S,R)-sulfoximine (BSO), a glutathione synthesis inhibitor,
exacerbates glutamate- or NMDA-induced neurotoxicity in
cortical cultures [8]. Increases in the release of reduced
glutathione in cerebral ischemia has been shown to exacerbate
the excitotoxic insult via NMDA receptors [9,10]. In this study,
we examined whether esculetin, a lipoxygenase inhibitor, can
rescue neuronal cells via modulatory actions on NMDA
receptors, and whether, in primary cortical cultures, its
protective actions can be ascribed to regulation of glutathione
metabolism, including antioxidant effects.
Materials and Methods
Mixed cortical cell cultures containing both glia and neurons,
were prepared from ICR mouse brains at 15-16 days of
gestation. Briefly, dissociated neocortical cells (3.5×10
5 cells/
well) were plated onto primaria-coated 24-well plates (Falcon)
containing a glial bed in plating medium consisting of Eagle’s
minimal essential medium (MEM; Earle’s salts, supplied
glutamine-free) supplemented with 20 mM glucose, 2 mM
L-glutamine, 5% fetal bovine serum, and 5% horse serum.
Cytosine arabinoside (10 µM) was added 5 days after plating
to halt the growth of non-neuronal cells.
Cultures were maintained at 37
oC in a humidified CO2
incubator and used for experiments between days 12 and
14 in vitro. Glial cultures were prepared from postnatal mice
(1-3 days) and plated at 1×10
5 cells/well in plating medium
supplemented with 10% horse serum, 10% fetal bovine serum,
and 10 ng/mL epidermal growth factor. After 2 weeks in vitro,
cytosine arabinoside was added to the cultures, which were
fed weekly with the same medium with 10% horse serum
used for mixed cultures. We added glycine (10 µM final
concentration) to all media. We pre-incubated cultures with
esculetin for 2 h before inducing neurotoxicity.
For measuring 
45Ca
2+ uptake, cultured cells were washed
with HEPES-buffered control salt solution (HCSS), and then
incubated with NMDA (150 µM) in the presence of MK-
801 (an NMDA receptor inhibitor, 10 µM) or esculetin (10,
100 µM) in HCSS containing CaCl2 (final activity: 1.0 µCi/
mL). After 5 min, exposure solution was washed away using
four boluses of HCSS and cells were lysed by addition of
0.2% sodium dodecyl sulfate solution. Aliquots of lysed cells
were added to scintillation counting solution for the counting
of beta emissions [11].
For protein preparation, cells from three culture plates were
pooled in 0.5 mL of 0.1 M phosphate buffer (pH 7.4) and
homogenized. The homogenate was centrifuged for 30 min
at 3,000 g at 4
oC and the supernatant, consisting of the
cytosolic+mitochondrial fractions, was used in enzyme assays
[12].
Glutathione peroxidase (GPx) activity was measured using
an NADPH reduction assay following the technique of
Lawrence and Burke [13]. Soluble cell proteins were added
to a reaction mixture containing reduced glutathione,
glutathione reductase, and NADPH in phosphate buffer. The
reaction was initiated by adding H2O2, the absorbance
decrease at 340 nm was recorded, and the activity in the
absence of cellular protein was subtracted. Results were based
on a molar extinction coefficient for NADPH of 6.22×10
3
M
−1 cm
−1. One unit of GPx is defined as µmoles NADPH
oxidized/min, and results are expressed in µmoles/min/mg
protein.
Glutathione reductase (GR) activity was measured using
an NADPH reduction assay following the technique of Eklöw
et al. [14] using oxidized glutathione disulfide (GSSG) as
substrate. GR activity was monitored by decreases in NADPH
absorbance at 340 nm at 37
oC. Results were based on a
molar extinction coefficient for NADPH of 6.22×10
3 M
−1
cm
−1. One unit of GR is defined as µmoles NADPH oxidized/
min, and results are expressed in µmoles/min/mg protein.
Protein content was measured by the method of Lowry et
al [15] with bovine serum albumin as a standard.
Neuronal damage was assessed by measuring the amount
of LDH released into the medium by damaged cells 24 h
after NMDA or BSO treatment. Morphological confirmation
was obtained by trypan blue staining. Data are expressed
as the mean±standard error of the mean (SEM) and analyzed
for statistical significance by one-way ANOVA using a post-
hoc Student-Neuman-Keuls test for multiple comparisons.
Results
Cultured cortical cells exposed to 150 µM NMDA or 50
µM kainic acid (KA) generated moderate (50-70%) neuronal
damage as indicated by increased LDH release into the bathing
medium after 24 h. Pre-exposure of esculetin (10, 100 µM)
for 2 h attenuated NMDA neurotoxicity by 16% and 29%,
respectively, but did not show any inhibitory effect against
KA neurotoxicity (Table 1). At the highest concentration,
esculetin significantly ameliorated NMDA-induced neuronal
injury. Esculetin dose-dependently and significantly inhibited
the neurotoxicity induced by H2O2 or superoxide anions
(O2
•−) produced by xanthine/xanthine oxidase co-treatment
(Table 2). Morphologically, NMDA-induced neurotoxicity
manifested as loss of cell bodies (Figure 1A); esculetin rescued
many neurons from NMDA neurotoxicity (Figure 1B). To
determine whether esculetin modulates NMDA receptors,Esculetin inhibits NMDA neurotoxicity 261
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we tested the effects of NMDA alone or NMDA+esculetin.
Uptake of 
45Ca
2+ increased after NMDA exposure for 5 min.
MK-801, a non-competitive NMDA receptor antagonist,
blocked 
45Ca
2+ uptake as well as LDH release. At 100 µM,
esculetin significantly ameliorated the NMDA-induced rise
in 
45Ca
2+ uptake (Figure 2). To investigate the interrelationship
Figure 1. Morphological evidence of neuroprotection by
esculetin against N-methyl-D-aspartate (NMDA) neurotoxicity.
Phase-contrast photomicrographs of sister cultures of neurons
cultured with NMDA (150 µM for 5 min) alone (A) or in the
presence of 100 mM esculetin (B). Neurons were stained with
trypan blue. Scale bar =50 µm.
Figure 2. Esculetin attenuates NMDA-induced 
45Ca
2+ uptake.
Sister cultures were exposed to 100 µM NMDA for 5 min in the
presence of extracellular 
45Ca
2+: immediately following
exposure, the cells were washed and lysed and intracellular
45Ca
2+ measured. Bars represents mean neuronal uptake after
NMDA exposure in the presence of MK-801 (10 µM) or
esculetin (10 or 100 µM). *
,**Significantly different from control
(*P<0.05, **P<0.01).
Figure 3. Esculetin concentration-dependently inhibits BSO-
induced neurotoxicity (A). Phase-contrast photomicrographs of
sister cultures of neurons cultured with vehicle (B), BSO (1 mM
for 24 h) alone (C) or in the presence of 30 µM esculetin (D).
*Significantly different from control (P<0.05). Scale bar=50 µm.
Table 1. In primary cortical cultures esculetin protects against
excitotoxic injury of neuronal cells induced by NMDA but not by
kainate
LDH released (%)
NMDA (150 µM) kainate (50 µM)
Control .100±4.4 .100±9.2
MK-801 or DNQX ..2.3±1.7** ..8.1±4.7** 
Esculetin (µM)
10 83.9±2.8 97.5±5.3
100 71.5±3.5* 92.5±5.5
*
,**Significantly different from control (*P<0.05, **P<0.01).
Table 2. Esculetin exhibits antioxidant activity against free
radical-mediated injuries in primary cortical cultures
LDH released (%)
H2O2 (300 µM)
 xanthine (0.5 mM)/
xanthine oxidase
(10 mU/mL)
Control 100±4 100±22
Esculetin (µM)
10 032±6* NT
30 022±3* 14±4*
100 012±1* 12±2*
NT: not tested. *Significantly different from control (P<0.001).262 Chang-Ryul Lee et al.
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between lipoxygenase (LOX) inhibition and glutathione
metabolism, we measured esculetin modifiable GSH
depletion-induced neurotoxicity. After 2-h pretreatment with
esculetin or vehicle, we exposed the cultured cells to 1 mM
BSO for 24 h. Esculetin, a LOX inhibitor (1, 10 or 30 µM)
significantly attenuated BSO-induced neuronal injury by 46,
62, and 73%, respectively (Figure 3A). We morphologically
confirmed the protective effect of 30 µM esculetin (Figures
3B-3D). At 150 µM arachidonic acid, the neuronal cells were
damaged 70-80%. Cycloheximide, an inhibitor of de novo
protein synthesis, and vitamin E, an antioxidant, reduced
neuronal damage by 25% (Figure 4). In contrast, esculetin
(100 µM) significantly inhibited the neuronal injury by 90%
(Figure 4). GPx activity was decreased by BSO treatment,
Figure 4. Esculetin, but not cycloheximide (CHX) or vitamin E
(Vit-E), significantly attenuates arachidonic acid (AA)-induced
neurotoxicity in mixed cortical cultures. *Significantly different
from control (P<0.05).
Figure 5. Esculetin does not change glutathione peroxidase (GP) activity (A) but increases glutathione reductase (GRx) activity (B)
in BSO neurotoxicity. *
,**Significantly different from normal (*P<0.05, **P<0.01). 
#,##Significantly different from BSO control (
#P<0.05,
##P<0.01). Esculetin inhibits NMDA neurotoxicity 263
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but BSO did not change GR activity at 24 h compared to
the normal group (Figures 5A and 5B). Here, esculetin at
3-30 µM concentration-dependently elevated GR activity
compared to BSO alone (Figure 5B) but caused little change
in GPx activity (Figure 5A). These findings suggest that esculetin
inhibits oxidized glutathione (GSSG) accumulation by
increasing GR activity, thus sparing the pool of reduced
glutathione (GSH).
Discussion
Ischemic injury, especially NMDA neurotoxicity, is known
to activate calcium-dependent lipoxygenase pathways [6].
So far, almost all NMDA antagonists have failed to protect
neuronal cells from cerebral ischemia clinically due to their
psychiatric side effects. In this study, esculetin, a non-
competitive lipoxygenase inhibitor, ameliorated NMDA-
induced neurotoxicity.
However, esculetin did not show protective effects against
KA neurotoxicity. These results are consistent with our previous
in vivo results [16]. In addition, we confirmed that the protective
effect of esculetin against NMDA toxicity can be partly
attributed to its ability to modulate NMDA receptors directly
or indirectly, as demonstrated by the results for calcium uptake.
When NMDA receptor overactivation is initiated by excitotoxic
insults, release of arachidonic acid and increases in
lipoxygenase activity can occur [6,17]. As in other reports,
esculetin strongly inhibited arachidonic acid-induced
neurotoxicity. The antioxidant vitamin E and the de novo
protein synthesis inhibitor cycloheximide exhibited only weak
protective effects. This means that esculetin may contribute
to the diminution of neuronal injury that occurs in ischemic
insults by attenuating the NMDA receptor-mediated
arachidonic acid cascade. Interestingly, esculetin also had a
sparing effect on the pool of GSH by halting GSH turnover
to GSSG. Esculetin induced a powerful inhibition of NMDA-
induced glutathione depletion. Furthermore, esculetin may
contribute to the rescue of neuronal cells from NMDA
neurotoxicity by scavenging H2O2 or O2
•−.
We conclude that esculetin is a potential neuroprotectant
in cerebral ischemia that appears to works by modulating
NMDA receptors and the metabolism of arachidonic acid
or glutathione.
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